🔎 Trials Near Me

Dachaigh › Obesity › Arizona › Tucson

Sgrùdaidhean clionaigeach Obesity ann an Tucson, AZ

Tha 17 sgrùdaidhean airson Obesity a’ lorg phàirtichean aig làraichean ann agus timcheall air Tucson (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

A’ fastadhÌre 2
  • Pima Heart, Tucson
  • Eclipse Clinical Research, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07783802

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

A’ fastadhÌre 3
  • University of Arizona, Tucson
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

A’ fastadhÌre 3
  • Tucson Clinical Research Institute, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

A’ fastadhÌre 3
  • Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

A’ fastadhÌre 3
  • Research Site, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

A’ fastadhÌre 3
  • Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

A’ fastadhÌre 2
  • The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

A’ fastadhÌre 3
  • AURORA-1 Clinical Site, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

A’ fastadhÌre 3
  • AURORA-2 Clinical Site, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

A’ fastadhÌre 3
  • Pima Heart and Vascular Clinical Research, Tucson
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

A’ fastadhÌre 3
  • Arizona Clinical Trials, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

A’ fastadhÌre 3
  • Arizona Clinical Trials, Tucson
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
  • ACCOMPLISH-2 Research Site, Tucson
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

A’ fastadhÌre 2
  • The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

A’ fastadhÌre 2
  • Pima Heart, Tucson
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07215559

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

A’ fastadhÌre 3
  • ACCOMPLISH-1 Research Site, Tucson
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07654361

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

A’ fastadhÌre 1/2
  • Adobe Clinical Research, Tucson
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06836609

Sgrùdaidhean Obesity ann am bailtean eile

Sgrùdaidhean eile ann an Tucson

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.